Stryker shares update — 7 notes

Written by Adam Schrag | January 31, 2017 | Print  |

Gateway Investment Advisers, owner of $2,560,000-worth Stryker shares, has cut back its stake in shares in the company.

Here are seven takeaways:


1. Stryker is a medical technology company with three segments: orthopaedics, medsurg and neurotechnology and spine.


2. Gateway sold 130 shares, cutting their stake in Stryker by 0.6 percent.


3. Around 74 percent of Stryker's stock is owned by hedge funds and other big investors.


4. Stryker has a one year low of $86.68 and a one year high of $123.55, and its 50-day moving average is $114.85. Its 200-day moving average is $115.80.


5. Stryker's last quarterly earnings data was issued on Oct. 27, when it reported a return on equity of 23.61 percent and a net margin of 15.24 percent.


6. Stryker reported earning $2.83 billion during the quarter, which beat out analysts' predictions that they would earn $2.81 billion. Stryker's revenue rose 17.1 percent from corresponding quarter in 2015 to 2016.


7. A current quarterly dividend was paid today, Jan. 31, 2017. 


More articles on devices:

Healthcare robotic market likely to grow in near future — 8 things to know:

Global neurology endoscopy devices market to grow at CAGR of 7%+ through 2021

SpinalCyte hopes CybroCell will usher in era of innovative spine treatment

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers